GR3004419T3 - - Google Patents

Info

Publication number
GR3004419T3
GR3004419T3 GR920400777T GR920400777T GR3004419T3 GR 3004419 T3 GR3004419 T3 GR 3004419T3 GR 920400777 T GR920400777 T GR 920400777T GR 920400777 T GR920400777 T GR 920400777T GR 3004419 T3 GR3004419 T3 GR 3004419T3
Authority
GR
Greece
Application number
GR920400777T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT8848388A external-priority patent/IT1235029B/it
Priority claimed from IT8848444A external-priority patent/IT1235032B/it
Priority claimed from IT8848445A external-priority patent/IT1235033B/it
Application filed filed Critical
Publication of GR3004419T3 publication Critical patent/GR3004419T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GR920400777T 1988-09-28 1992-04-20 GR3004419T3 (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT8848388A IT1235029B (it) 1988-09-28 1988-09-28 Composizione farmaceutica comprendente inosiplex e zidovudina per il trattamento dell'aids e sindromi correlate
IT8848444A IT1235032B (it) 1988-10-12 1988-10-12 Composizione farmaceutica comprendente inosina,acido p-acetammidobenzoico e zidovudina per il trattamento dell'aids e sindromi correlate
IT8848445A IT1235033B (it) 1988-10-12 1988-10-12 Composizione farmaceutica comprendente acido p-acetammidobenzoico e zidovudina per il trattamento dell'aids e sindromi correlate

Publications (1)

Publication Number Publication Date
GR3004419T3 true GR3004419T3 (enExample) 1993-03-31

Family

ID=27273668

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400777T GR3004419T3 (enExample) 1988-09-28 1992-04-20

Country Status (6)

Country Link
US (1) US5108993A (enExample)
EP (1) EP0362162B1 (enExample)
JP (1) JPH02142733A (enExample)
DE (1) DE68900926D1 (enExample)
ES (1) ES2038847T3 (enExample)
GR (1) GR3004419T3 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE131730T1 (de) * 1991-05-16 1996-01-15 Glaxo Group Ltd Nukleosidanalogen enthaltende antiviren- zubereitungen
EP0684818B1 (en) * 1993-02-22 1999-05-06 Janssen Pharmaceutica N.V. Method of reversing resistance of hiv-1 strains to zidovudine
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
DE69834527T2 (de) 1997-07-01 2007-05-10 VLP Watertown Limited Partnership, Watertown Verfahren zur Geschlechtsbestimmung von Säuger-Nachkommenschaft
US7090839B2 (en) 2000-09-01 2006-08-15 Hidden Valley, N.V. Method of treatment of human immunodeficiency diseases
WO2003013544A1 (es) * 2001-08-08 2003-02-20 Laboratorios Químicos Industriales, S.A. Medicamento antiviral para utilizarse en el control de la enfermedad mancha blanca en camarones
WO2008035894A1 (en) 2006-09-19 2008-03-27 Sungkyunkwan University Foundation For Corporate Collaboration Antiviral agent against animal viruses
US20100130439A1 (en) * 2007-04-26 2010-05-27 Romesberg Floyd E Genomic mutation inhibitors that inhibit y family dna polymerases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK167377B1 (da) * 1985-09-17 1993-10-25 Wellcome Found 3'-azidopyrimidinnucleosider eller farmaceutisk acceptable salte eller estere deraf til anvendelse ved behandling af eller profylakse for en human retrovirusinfektion
US4866035A (en) * 1987-10-05 1989-09-12 Merck & Co., Inc. Dipeptidyl saccharides as host resistance enhancers in AIDS-immuno-compromised hosts and methods of use

Also Published As

Publication number Publication date
DE68900926D1 (de) 1992-04-09
EP0362162A3 (en) 1990-05-30
ES2038847T3 (es) 1993-08-01
EP0362162B1 (en) 1992-03-04
JPH02142733A (ja) 1990-05-31
US5108993A (en) 1992-04-28
EP0362162A2 (en) 1990-04-04

Similar Documents

Publication Publication Date Title
FR2632846B1 (enExample)
FR2686034B1 (enExample)
AU7316987A (enExample)
AU1432188A (enExample)
AU2497488A (enExample)
AU7677887A (enExample)
AU7636887A (enExample)
AU7296287A (enExample)
AU8087987A (enExample)
AU7323787A (enExample)
AU1273688A (enExample)
AU7574987A (enExample)
AU1529688A (enExample)
AU7900787A (enExample)
AU1670288A (enExample)
IN172623B (enExample)
IN169335B (enExample)
IN167069B (enExample)
BG45312A1 (enExample)
BG45449A1 (enExample)
BG45264A1 (enExample)
BG45406A1 (enExample)
BG45469A1 (enExample)
BG45513A1 (enExample)
BG45445A1 (enExample)